JDBIO Captivates Visitors at KIMES 2026 with Unique Booth Experience and New Product Launches
JDBIO Co., Ltd. participated in the 41st Korea International Medical & Hospital Equipment Show (KIMES 2026), held from March 19 to 22 at COEX in Gangnam, where the company showcased its medical aesthetics technologies and new product lineup, drawing strong interest from visitors.
KIMES is the largest medical device and hospital equipment exhibition in Korea and serves as a global business platform where the latest medical devices and healthcare technologies can be explored in one place. It has established itself as a leading event that brings together numerous medical professionals and buyers each year to share industry trends.
Maximizing Visibility through Strategic Location and Unique Booth Operations
JDBIO secured a highly visible booth location at the COEX Hall A lobby (AL200). Positioned at a key intersection connecting the exhibition entrance and major visitor pathways, the booth benefited from natural foot traffic and high exposure. This strategic placement effectively enhanced brand awareness, attracting a steady stream of both domestic and international visitors throughout the event.
Inside the spacious 74㎡ booth, JDBIO introduced a unique experiential space called the “JD BAR.” Visitors were able to enjoy beer and beverages while engaging in product consultations and experiencing the brand in a relaxed setting. This “stay-type booth strategy” went beyond a traditional exhibition format, creating an environment for deeper brand interaction and receiving enthusiastic responses from attendees.
Showcasing Advanced Medical Aesthetic Technologies with New Skin Booster and Toxin Products
During KIMES 2026, JDBIO presented a comprehensive lineup of new products, including skin boosters and toxin formulations, highlighting its technological capabilities.
“RICHESSE™ TRINITY90 with RH” is a multi-functional skin booster based on RH collagen, PN, PDRN, and HA, designed to simultaneously promote skin regeneration and provide nourishment. It stimulates collagen synthesis and supports the skin’s natural recovery process, helping to improve wrinkles, pigmentation, acne scars, as well as enhancing elasticity and radiance.
“RICHESSE™ TX” is a high-purity botulinum toxin type A product, manufactured using Microwave Vacuum Drying (MVD) technology to minimize protein denaturation and ensure high purity and stability. It offers rapid onset and consistent results, helping to create balanced facial contours while maintaining natural expressions.
In addition, “DEMEI™ PLA/PCL” is a next-generation polymer-based skin booster, where PLA promotes collagen production and improves skin structure, while PCL provides long-lasting volume retention for up to 24 months and delivers natural-looking results. “DEMEI™ BODY 60/100” is a high-purity HA (24mg/mL)-based body filler, designed for precise body contouring and long-term structural stability, enhancing the overall quality of aesthetic procedures.
Through its participation in KIMES 2026, JDBIO successfully strengthened its brand awareness and expanded its network with domestic and international buyers. Moving forward, the company aims to further solidify its position as a leader in the K-medical aesthetics market through continuous R&D and participation in global exhibitions.